Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-006972
Filing Date
2020-05-07
Accepted
2020-05-07 16:32:35
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rdus03312010-q.htm   iXBRL 10-Q 1297099
2 EXHIBIT 31.1 rdus03312010qex31d1.htm EX-31.1 11850
3 EXHIBIT 31.2 rdus03312010qex31d2.htm EX-31.2 11827
4 EXHIBIT 32.1 rdus03312010qex32d1.htm EX-32.1 12806
  Complete submission text file 0001628280-20-006972.txt   5796524

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rdus-20200331.xsd EX-101.SCH 33811
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rdus-20200331_cal.xml EX-101.CAL 70798
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rdus-20200331_def.xml EX-101.DEF 190000
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rdus-20200331_lab.xml EX-101.LAB 468988
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rdus-20200331_pre.xml EX-101.PRE 301869
59 EXTRACTED XBRL INSTANCE DOCUMENT rdus03312010-q_htm.xml XML 1008917
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35726 | Film No.: 20856998
SIC: 2834 Pharmaceutical Preparations